 |
Repertoire Immune Medicines
Last updated: January 20, 2024
John Cox, CEO
Country: USA | Funding: $257.3M (+)
Website: https://www.repertoire.com/
Repertoire Immune Medicines advances anti-cancer T-cell therapies through the clinic while expanding its immune response drug discovery platform.
Website: https://www.repertoire.com/
Repertoire Immune Medicines advances anti-cancer T-cell therapies through the clinic while expanding its immune response drug discovery platform.